标题
Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
作者
关键词
-
出版物
Marine Drugs
Volume 11, Issue 12, Pages 903-933
出版商
MDPI AG
发表日期
2013-03-16
DOI
10.3390/md11030903
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia
- (2013) I. M. Ghobrial et al. BLOOD
- Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma
- (2013) V. Ribrag et al. HAEMATOLOGICA
- Newly discovered angiogenesis inhibitors and their mechanisms of action
- (2012) Ze-hong Miao et al. ACTA PHARMACOLOGICA SINICA
- Unusual expression of red fluorescence at M phase induced by anti-microtubule agents in HeLa cells expressing the fluorescent ubiquitination-based cell cycle indicator (Fucci)
- (2012) Asumi Honda-Uezono et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab
- (2012) Nora M. Barboza et al. CANCER BIOLOGY & THERAPY
- Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors
- (2012) John H. Strickler et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors
- (2012) Suzanne F. Jones et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Low-dose laulimalide represents a novel molecular probe for investigating microtubule organization
- (2012) Melissa J. Bennett et al. CELL CYCLE
- Resampling Phase III Data to Assess Phase II Trial Designs and Endpoints
- (2012) M. R. Sharma et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors: New Promise in the Treatment of Immune and Inflammatory Diseases
- (2012) Stephen J. Shuttleworth et al. CURRENT DRUG TARGETS
- The Development of MetAP-2 Inhibitors in Cancer Treatment
- (2012) S.-Q. Yin et al. CURRENT MEDICINAL CHEMISTRY
- Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial
- (2012) Madeleine Duvic et al. EUROPEAN JOURNAL OF CANCER
- Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
- (2012) Berkley E Gryder et al. Future Medicinal Chemistry
- Antibacterial efficacy of inhaled squalamine in a rat model of chronic Pseudomonas aeruginosa pneumonia
- (2012) S. Hraiech et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- Structural Analysis of Bengamide Derivatives as Inhibitors of Methionine Aminopeptidases
- (2012) Wei Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Shark cartilage: has the popularisation of science failed?
- (2012) Constantine Alifrangis et al. LANCET ONCOLOGY
- Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma
- (2012) Massimo Offidani et al. LEUKEMIA & LYMPHOMA
- Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma
- (2012) Jeffrey L. Wolf et al. LEUKEMIA & LYMPHOMA
- The Alkaloid Ageladine A, Originally Isolated from Marine Sponges, Used for pH-Sensitive Imaging of Transparent Marine Animals
- (2012) Ulf Bickmeyer Marine Drugs
- Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance
- (2012) Ioana Abraham et al. Marine Drugs
- The Antiangiogenic Compound Aeroplysinin-1 Induces Apoptosis in Endothelial Cells by Activating the Mitochondrial Pathway
- (2012) Beatriz Martínez-Poveda et al. Marine Drugs
- Fucoidan extract derived from Undaria pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells
- (2012) Fang Liu et al. PHYTOMEDICINE
- FASCAPLYSIN as a Specific Inhibitor for CDK4: Insights from Molecular Modelling
- (2012) Muhammad Imtiaz Shafiq et al. PLoS One
- Anticancer Properties and Mechanisms of Fucoidan on Mouse Breast Cancer In Vitro and In Vivo
- (2012) Meilan Xue et al. PLoS One
- Incorporated nematocysts in Aeolidiella stephanieae (Gastropoda, Opisthobranchia, Aeolidoidea) mature by acidification shown by the pH sensitive fluorescing alkaloid Ageladine A
- (2012) Dana Obermann et al. TOXICON
- Squalamine and its derivatives as potential antitubercular compounds
- (2012) Brian T. Walker et al. TUBERCULOSIS
- Matrix metalloproteinases in vascular physiology and disease
- (2012) Suzanne A Siefert et al. Vascular
- New Proteasome Inhibitors in Myeloma
- (2012) Panisinee Lawasut et al. Current Hematologic Malignancy Reports
- Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome
- (2011) Sophie Dimicoli et al. AMERICAN JOURNAL OF HEMATOLOGY
- Arthrinins A–D: Novel diterpenoids and further constituents from the sponge derived fungus Arthrinium sp.
- (2011) Sherif S. Ebada et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma
- (2011) John D. Hainsworth et al. CANCER INVESTIGATION
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: An Innovative Therapies for Children with Cancer (ITCC) study
- (2011) Birgit Geoerger et al. EUROPEAN JOURNAL OF CANCER
- Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model
- (2011) Xiaojun Yan et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
- (2011) Michael Millward et al. INVESTIGATIONAL NEW DRUGS
- Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel
- (2011) Michael Millward et al. INVESTIGATIONAL NEW DRUGS
- A One-Pot Synthesis and Biological Activity of Ageladine A and Analogues
- (2011) Sudhir R. Shengule et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of the Cytoskeleton in Formation and Maintenance of Angiogenic Sprouts
- (2011) Kayla J. Bayless et al. JOURNAL OF VASCULAR RESEARCH
- Plitidepsin Has a Safe Cardiac Profile: A Comprehensive Analysis
- (2011) Arturo Soto-Matos et al. Marine Drugs
- Mechanism of Action of Proteasome Inhibitors and Deacetylase Inhibitors and the Biological Basis of Synergy in Multiple Myeloma
- (2011) T. Hideshima et al. MOLECULAR CANCER THERAPEUTICS
- Phase II Study of Plitidepsin 3-Hour Infusion Every 2 Weeks in Patients With Unresectable Advanced Medullary Thyroid Carcinoma
- (2010) Eric Baudin et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Anti-microtubule ‘plinabulin’ chemical probe KPU-244-B3 labeled both α- and β-tubulin
- (2010) Yuri Yamazaki et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis, and biological evaluation of dibromotyrosine analogues inspired by marine natural products as inhibitors of human prostate cancer proliferation, invasion, and migration
- (2010) Asmaa A. Sallam et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)
- (2010) N. Fortunati et al. BREAST CANCER RESEARCH AND TREATMENT
- Discovery and Characterization of the Laulimalide-Microtubule Binding Mode by Mass Shift Perturbation Mapping
- (2010) Melissa J. Bennett et al. CHEMISTRY & BIOLOGY
- Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma
- (2010) M. V. Mateos et al. CLINICAL CANCER RESEARCH
- Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin(NPI-2358) in Patients with Solid Tumors or Lymphomas
- (2010) M. M. Mita et al. CLINICAL CANCER RESEARCH
- Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
- (2010) D. Mottet et al. CURRENT CANCER DRUG TARGETS
- The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis
- (2010) Andrea S. Rothmeier et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study
- (2010) Robert J. Morgan et al. INVESTIGATIONAL NEW DRUGS
- Antiangiogenic Metabolites from a Marine-Derived Fungus,Hypocrea vinosa
- (2010) Yuu Ohkawa et al. JOURNAL OF NATURAL PRODUCTS
- Reversal of TNP-470-Induced Endothelial Cell Growth Arrest by Guanine and Guanine Nucleosides
- (2010) J. Hines et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial
- (2010) Charles Lu et al. JNCI-Journal of the National Cancer Institute
- Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ
- (2010) Kazuhiro Irie et al. MEDICINAL RESEARCH REVIEWS
- The odyssey of marine pharmaceuticals: a current pipeline perspective
- (2010) Alejandro M.S. Mayer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant
- (2009) Paul M. Barr et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cortistatin A is a High-Affinity Ligand of Protein Kinases ROCK, CDK8, and CDK11
- (2009) Victor J. Cee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Pyripyropenes, Fungal Sesquiterpenes Conjugated with α-Pyrone and Pyridine Moieties, Exhibits Anti-angiogenic Activity against Human Umbilical Vein Endothelial Cells
- (2009) Asami Hayashi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Direct effects of fascaplysin on human umbilical vein endothelial cells attributing the anti-angiogenesis activity
- (2009) Y.L. Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Control of HIF-1 Expression by eIF2 Phosphorylation-Mediated Translational Repression
- (2009) K. Zhu et al. CANCER RESEARCH
- Antivascular Actions of Microtubule-Binding Drugs
- (2009) E. L. Schwartz CLINICAL CANCER RESEARCH
- Clinical Studies of Histone Deacetylase Inhibitors
- (2009) H. M. Prince et al. CLINICAL CANCER RESEARCH
- Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma
- (2009) Patrick Schöffski et al. Marine Drugs
- Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma
- (2009) Tim Eisen et al. MELANOMA RESEARCH
- Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib
- (2009) Constantine S. Mitsiades et al. SEMINARS IN HEMATOLOGY
- Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells
- (2008) Yoichi Nakao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma
- (2008) J Caers et al. BRITISH JOURNAL OF CANCER
- Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
- (2008) Geoffrey Y. Ku et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Investigation of the marine compound spongistatin 1 links the inhibition of PKCα translocation to nonmitotic effects of tubulin antagonism in angiogenesis
- (2008) Andrea S. Rothmeier et al. FASEB JOURNAL
- Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer
- (2008) Tim Eisen et al. LUNG CANCER
- Streptopyrrolidine, an angiogenesis inhibitor from a marine-derived Streptomyces sp. KORDI-3973
- (2008) Hee Jae Shin et al. PHYTOCHEMISTRY
- The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo
- (2008) Jingui Ma et al. PLoS One
- The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8
- (2008) W. Wrasidlo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells
- (2007) Mee Young Ahn et al. GYNECOLOGIC ONCOLOGY
- Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer
- (2007) Christian Peschel et al. LUNG CANCER
- A polysaccharide isolated from the brown seaweed Sargassum stenophyllum exerts antivasculogenic effects evidenced by modified morphogenesis
- (2007) Paulo Fernando Dias et al. MICROVASCULAR RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now